Travoprost and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Travoprost (travoprost) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include nerve injury among females and dysuria among males.

The phase IV clinical study analyzes what interactions people have when they take Travoprost and Combivent. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Travoprost?

Travoprost has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 3,333 Travoprost users. Check the latest studies of Travoprost.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

On Jul, 16, 2026

13 people who take Travoprost and Combivent together, and have interactions are studied.

Travoprost and Combivent drug interactions.

What are the common drug interactions of Travoprost and Combivent, by gender? *:

female:

Nerve injury
Cardiac disorder
Pneumonia
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Seasonal allergy (allergic condition due to certain season)
Urinary tract infection
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Carpal tunnel decompression
Exposure to toxic agent
Injection site erythema (redness at injection site)

male:

Dysuria (painful or difficult urination)
Abdominal pain
Abdominal pain upper
Constipation
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Priapism (prolonged and painful erection that can last from several hours up to a few days)
Renal disorder (kidney disease)
Vomiting

What are the common drug interactions of Travoprost and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Cardiac disorder
Nerve injury
Injection site erythema (redness at injection site)
Abdominal pain
Abdominal pain upper
Constipation
Death
Fatigue (feeling of tiredness)
Feeding disorder (when children refuse to eat certain food groups)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 46.15%
Iron Deficiency Anaemia: 2 people, 15.38%
Thyroid Diseases: 1 person, 7.69%
Stress And Anxiety: 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Quit Smoking: 1 person, 7.69%
Parkinson's Disease: 1 person, 7.69%
Panic Disorder: 1 person, 7.69%
Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Travoprost and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously